Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England.
Woods B, Kearns B, Schmitt L, Jankovic D, Rothery C, Harnan S, Hamilton J, Scope A, Ren S, Bojke L, Wilcox M, Hope W, Leonard C, Howard P, Jenkins D, Ashworth A, Bentley A, Sculpher M. Woods B, et al. Among authors: wilcox m. Appl Health Econ Health Policy. 2024 Nov 30. doi: 10.1007/s40258-024-00924-x. Online ahead of print. Appl Health Econ Health Policy. 2024. PMID: 39616299
Distribution of Clostridioides difficile ribotypes and sequence types across humans, animals and food in 13 European countries.
Rupnik M, Viprey V, Janezic S, Tkalec V, Davis G, Sente B, Devos N, Muller BH, Santiago-Allexant E, Cleuziat P, Wilcox M, Davies K; COMBACTE-CDI consortium. Rupnik M, et al. Among authors: wilcox m. Emerg Microbes Infect. 2024 Dec;13(1):2427804. doi: 10.1080/22221751.2024.2427804. Epub 2024 Nov 27. Emerg Microbes Infect. 2024. PMID: 39535868 Free PMC article.
A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults.
Peterson RD, Guarneiri LL, Adams CG, Wilcox ML, Clark AJ, Rudemiller NP, Maki KC, Malinczak CA. Peterson RD, et al. Among authors: wilcox ml. Int J Toxicol. 2024 Oct 28:10915818241293723. doi: 10.1177/10915818241293723. Online ahead of print. Int J Toxicol. 2024. PMID: 39465888 Free article.
Optimization of SARS-CoV-2 culture from clinical samples for clinical trial applications.
Wooding D, Buist K, Romero-Ramirez A, Savage H, Watkins R, Bengey D, Greenland-Bews C, Thompson CR, Kontogianni N, Body R, Hayward G, Byrne RL, Gould S; CONDOR Steering Group; Myerscough C, Atkinson B, Shaw V, Greenhalf B, Adams E, Cubas-Atienzar A, Khoo S, Fletcher T, Edwards T. Wooding D, et al. mSphere. 2024 Nov 21;9(11):e0030424. doi: 10.1128/msphere.00304-24. Epub 2024 Oct 16. mSphere. 2024. PMID: 39412283 Free PMC article.
CLOVER: A Phase 3 Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection.
Donskey CJ, Dubberke ER, Klein NP, Liles EG, Szymkowiak K, Wilcox MH, Lawrence J, Bouguermouh S, Zhang H, Koury K, Bailey R, Smith HM, Lockhart S, Lamberth E, Kalina WV, Pride MW, Webber C, Anderson AS, Jansen KU, Gruber WC, Kitchin N. Donskey CJ, et al. Among authors: wilcox mh. Clin Infect Dis. 2024 Aug 24:ciae410. doi: 10.1093/cid/ciae410. Online ahead of print. Clin Infect Dis. 2024. PMID: 39180325
1,116 results